This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2007 Feb;30(2):395-402.

doi: 10.2337/dc06-1569.

Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach

Michael Freemark¹

Affiliations

PMID: 17259519
DOI: 10.2337/dc06-1569

Review

Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach

Michael Freemark. Diabetes Care. 2007 Feb.

. 2007 Feb;30(2):395-402.

doi: 10.2337/dc06-1569.

Author

Michael Freemark¹

Affiliation

¹ Box 3080, Duke University Medical Center, Durham, NC 27710, USA. freem001@mc.duke.edu

PMID: 17259519
DOI: 10.2337/dc06-1569

No abstract available

PubMed Disclaimer

Similar articles

[Pharmacotherapy of obesity].
Svendsen OL. Svendsen OL. Ugeskr Laeger. 2004 Oct 18;166(43):3814-7. Ugeskr Laeger. 2004. PMID: 15544112 Danish. No abstract available.
[Pharmacotherapy for weight loss in patients with type 2 diabetes].
Toubro S. Toubro S. Ugeskr Laeger. 2007 Aug 13;169(33):2619-22. Ugeskr Laeger. 2007. PMID: 17725907 Danish. No abstract available.
[Novel anti-obesity drugs].
Tripp B, Ludvik B. Tripp B, et al. Acta Med Austriaca. 2004;31(4):133-8. Acta Med Austriaca. 2004. PMID: 15732249 Review. German.
Rimonabant, obesity and diabetes.
[No authors listed] [No authors listed] Prescrire Int. 2007 Jun;16(89):122. Prescrire Int. 2007. PMID: 17585427
Obesity pharmacotherapy from a regulatory perspective: overview and key challenges.
Hutchinson NI, Ryder SW. Hutchinson NI, et al. Clin Pharmacol Ther. 2007 May;81(5):756-60. doi: 10.1038/sj.clpt.6100169. Epub 2007 Mar 28. Clin Pharmacol Ther. 2007. PMID: 17392723 Review.

See all similar articles

Cited by

Pediatric obesity pharmacotherapy: current state of the field, review of the literature and clinical trial considerations.
Kelly AS, Fox CK, Rudser KD, Gross AC, Ryder JR. Kelly AS, et al. Int J Obes (Lond). 2016 Jul;40(7):1043-50. doi: 10.1038/ijo.2016.69. Epub 2016 Apr 26. Int J Obes (Lond). 2016. PMID: 27113643 Free PMC article. Review.
Pharmacotherapy in pediatric obesity: current agents and future directions.
Wald AB, Uli NK. Wald AB, et al. Rev Endocr Metab Disord. 2009 Sep;10(3):205-14. doi: 10.1007/s11154-009-9111-y. Rev Endocr Metab Disord. 2009. PMID: 19688265 Review.
Unlicensed use of metformin in children and adolescents in the UK.
Hsia Y, Dawoud D, Sutcliffe AG, Viner RM, Kinra S, Wong IC. Hsia Y, et al. Br J Clin Pharmacol. 2012 Jan;73(1):135-9. doi: 10.1111/j.1365-2125.2011.04063.x. Br J Clin Pharmacol. 2012. PMID: 21762204 Free PMC article.
Is There a Prescription to Treat Pediatric Obesity?
Srivastava SB. Srivastava SB. Am J Lifestyle Med. 2019 Oct 24;14(1):36-39. doi: 10.1177/1559827619881095. eCollection 2020 Jan-Feb. Am J Lifestyle Med. 2019. PMID: 31903078 Free PMC article.
Pediatric obesity: etiology and treatment.
Crocker MK, Yanovski JA. Crocker MK, et al. Endocrinol Metab Clin North Am. 2009 Sep;38(3):525-48. doi: 10.1016/j.ecl.2009.06.007. Endocrinol Metab Clin North Am. 2009. PMID: 19717003 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information